QPS Austria, part of QPS Holdings, LLC, is a full-service contract research organization (CRO). The company performs preclinical as well as clinical research. QPS Neuropharmacology is well known as a leading CRO for CNS drug development. The availability of the most predictive disease models and unparalleled experience with studies performed for biopharmaceutical companies of all sizes turn QPS into the first choice for most research needs. Validated transgenic and non-transgenic in vitro and in vivo models cover most targets of Alzheimer's-, Parkinson's-, Huntington's disease, other neurodegenerative disorders and Orphan diseases. The clinical research team ensures an efficient development process from First-in-Man (Phase I) up to and including Post-Marketing-Surveillance-Studies (Phase IV). Our customers benefit from the competent teams at QPS Austria, the use of innovative technology as well as scientific and clinical expertise together with a worldwide network. Check out our websites for detailed information: Neuropharmacolgy: www.qpsneuro.com Clinical Research Services: www.qps.com/ser-clinical-development.php